0001209191-22-059756.txt : 20221205 0001209191-22-059756.hdr.sgml : 20221205 20221205171046 ACCESSION NUMBER: 0001209191-22-059756 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221130 FILED AS OF DATE: 20221205 DATE AS OF CHANGE: 20221205 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FALBERG KATHRYN E CENTRAL INDEX KEY: 0001206977 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39351 FILM NUMBER: 221445798 MAIL ADDRESS: STREET 1: C/O AXOVANT SCIENCES, INC. STREET 2: 320 WEST 37TH STREET, 5TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10018 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nuvation Bio Inc. CENTRAL INDEX KEY: 0001811063 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850862255 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 754-3517 MAIL ADDRESS: STREET 1: 357 TEHAMA STREET, FLOOR 3 CITY: SAN FRANCISCO STATE: CA ZIP: 94103 FORMER COMPANY: FORMER CONFORMED NAME: Panacea Acquisition Corp DATE OF NAME CHANGE: 20200430 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-11-30 0 0001811063 Nuvation Bio Inc. NUVB 0001206977 FALBERG KATHRYN E C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036 1 0 0 0 Class A Common Stock 2022-11-30 4 P 0 75041 1.8535 A 75041 I By Trust Class A Common Stock 2022-12-01 4 P 0 84959 1.9727 A 160000 I By Trust Class A Common Stock 2022-12-02 4 P 0 47000 1.9827 A 207000 I By Trust Class A Common Stock 2022-12-05 4 P 0 43000 1.9526 A 250000 I By Trust Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.805 to $1.90. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Shares are held directly by The Falberg-Predovich Family Trust, of which the Reporting Person is Co-Trustee. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.92 to $1.99. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.925 to $2.00. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Kathryn E. Falberg, by /s/ Ron A. Metzger, Attorney-in-Fact 2022-12-05